Aurobindo Pharma USA, a subsidiary of India-based Aurobindo Pharma Limited, a pharmaceutical manufacturer headquartered at Hyderabad, India, announced this week that it will be building a new manufacturing and distribution center in New Jersey. Aurobindo acquired a 90-acre tract on Windsor Center Drive in East Windsor, New Jersey; no financial information on the land purchase or the scope of the warehouse-distribution facility was released. The purchased property is located across from Route 133 and near the 43,000 square foot Patscentre building, now occupied by Novo Tech, a new Township pharmaceutical R&D company.
Mayor Mironov said of the firm's expansion, "We are excited that Aurobindo has chosen East Windsor for their new warehouse and distribution center, bringing new tax dollars and new jobs to our community. This expansion here by Aurobindo, a global corporation, represents the attraction to East Windsor of another high-tech, high growth-potential company in our Einstein's Alley corridor. East Windsor is a great location for this type of company, and we are pleased to add Aurobindo to the many pharmaceutical related firms which have chosen to locate in East Windsor, including Novotec Pharma, Hovione, Elementis, CorTech Solutions, Aprecia, Aurex Laboratories, Sabinsa, and Windsor Labs."
In a statement, Aurobindo USA's CEO Robert Cunard added, "We at Aurobindo Pharma are very excited about our recent acquisition and planned expansion into East Windsor. We have appreciated the valuable assistance and guidance of the mayor and her team, who have been great partners and extremely helpful to our company in moving forward with our acquisition and planned expansion." The new facility is expected to generate at least 300 new jobs at the East Windsor location when fully operational.
For more news and information visit Blumberg Capital Partners.
No comments:
Post a Comment